Comsol
Case Studies
Enhancing Performance and Safety of Medical Implantable Devices with Multiphysics Simulation
Overview
Enhancing Performance and Safety of Medical Implantable Devices with Multiphysics SimulationComsol |
Analytics & Modeling - Digital Twin / Simulation Analytics & Modeling - Predictive Analytics Analytics & Modeling - Real Time Analytics | |
Healthcare & Hospitals Life Sciences | |
Product Research & Development Quality Assurance | |
Predictive Maintenance Remote Patient Monitoring Digital Twin | |
Software Design & Engineering Services System Integration | |
Operational Impact
Many simulations were used in the development of the centrifugal pump of the LVAD. One challenge associated with engineering these devices is the prevention of blood clotting in any space in or around the pump. To address this, a magnetically levitated rotor was developed, which eliminated the need for ball bearings and other components with geometries that might promote clotting. Hansen used the Rotating Machinery modeling technology available in the software to model both the magnetically levitated rotor and turbulent fluid flow. | |
A permanent magnet in the pump rotor is driven by coils in the stator, which exert a torque on the rotor and provide active control of the position of the rotor axis. The vertical position — or levitation — of the rotor is accomplished by magnetic field line tension and does not need active control. The rotor receives blood axially and redirects it radially, into the volute, or fluid collector. Some of the blood flows back around the outer edge of the rotor and into the rotor inlet, resulting in a constant washing of the blood, which serves to eliminate places where the blood can stagnate and clot. | |
Another significant advance was the development of a pump system with pulsatile flow, rather than continuous flow, which more closely mimics a functioning heart. The pulsatile flow aids in the washing of the blood, preventing blood clots, and is also believed to have a positive physiological effect on blood vessels throughout the body. | |
Quantitative Benefit
Hansen has created upwards of 230 models addressing a wide range of design challenges. | |
Thoratec, now part of St. Jude Medical, brought LVADs to a wide market in 2010 after years of clinical trials. | |